Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.

Polireddy K, Chavan H, Abdulkarim BA, Krishnamurthy P.

Mol Oncol. 2011 Oct;5(5):410-25. doi: 10.1016/j.molonc.2011.07.005. Epub 2011 Jul 28.

PMID:
21849266
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma.

Sukowati CH, Rosso N, Pascut D, Anfuso B, Torre G, Francalanci P, Crocè LS, Tiribelli C.

BMC Gastroenterol. 2012 Nov 15;12:160. doi: 10.1186/1471-230X-12-160.

PMID:
23153066
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.

Lu GD, Leung CH, Yan B, Tan CM, Low SY, Aung MO, Salto-Tellez M, Lim SG, Hooi SC.

Gastroenterology. 2010 Aug;139(2):632-43, 643.e1-4. doi: 10.1053/j.gastro.2010.03.051. Epub 2010 Mar 27.

PMID:
20347819
[PubMed - indexed for MEDLINE]
4.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

PMID:
22815774
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.

Li Y, Zhu Z, Zhang S, Yu D, Yu H, Liu L, Cao X, Wang L, Gao H, Zhu M.

PLoS One. 2011 Mar 15;6(3):e17794. doi: 10.1371/journal.pone.0017794.

PMID:
21423629
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.

Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH.

Hum Pathol. 2012 Jul;43(7):1084-93. doi: 10.1016/j.humpath.2011.08.019. Epub 2011 Dec 26.

PMID:
22204716
[PubMed - indexed for MEDLINE]
7.

Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.

Cai J, Zhao XL, Liu AW, Nian H, Zhang SH.

Phytomedicine. 2011 Mar 15;18(5):366-73. doi: 10.1016/j.phymed.2010.08.006. Epub 2010 Sep 20.

PMID:
20850954
[PubMed - indexed for MEDLINE]
8.

Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.

Rong M, Chen G, Dang Y.

BMC Cancer. 2013 Jan 16;13:21. doi: 10.1186/1471-2407-13-21.

PMID:
23320393
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.

Su J, You P, Zhao JP, Zhang SL, Song SH, Fu ZR, Ye LW, Zi XY, Xie DF, Zhu MH, Hu YP.

Med Oncol. 2012 Jun;29(2):1059-67. doi: 10.1007/s12032-011-9989-6. Epub 2011 Jun 8.

PMID:
21656028
[PubMed - indexed for MEDLINE]
10.

Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.

Gao J, Ding F, Liu Q, Yao Y.

Mol Cell Biochem. 2013 Apr;376(1-2):21-32. doi: 10.1007/s11010-012-1545-y. Epub 2012 Dec 12.

PMID:
23232575
[PubMed - indexed for MEDLINE]
11.

Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.

Park SY, Han J, Kim JB, Yang MG, Kim YJ, Lim HJ, An SY, Kim JH.

Eur J Cancer. 2014 Jan;50(2):341-50. doi: 10.1016/j.ejca.2013.09.021. Epub 2013 Oct 22.

PMID:
24161763
[PubMed - indexed for MEDLINE]
12.

Aberrant upregulation of LRRC1 contributes to human hepatocellular carcinoma.

Li Y, Zhou B, Dai J, Liu R, Han ZG.

Mol Biol Rep. 2013 Jul;40(7):4543-51. doi: 10.1007/s11033-013-2549-8. Epub 2013 May 6.

PMID:
23645086
[PubMed - indexed for MEDLINE]
13.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
[PubMed - indexed for MEDLINE]
14.

Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.

Sun W, Dong WW, Mao LL, Li WM, Cui JT, Xing R, Lu YY.

World J Gastroenterol. 2013 May 21;19(19):2913-20. doi: 10.3748/wjg.v19.i19.2913.

PMID:
23704824
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.

Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J.

Anat Rec (Hoboken). 2013 Oct;296(10):1568-75. doi: 10.1002/ar.22737. Epub 2013 Jul 22.

PMID:
23878061
[PubMed - indexed for MEDLINE]
16.

Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.

Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.

Chin Med J (Engl). 2011 Nov;124(22):3794-9.

PMID:
22340243
[PubMed - indexed for MEDLINE]
Free Article
17.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

PMID:
22028922
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.

J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.

PMID:
21419759
[PubMed - indexed for MEDLINE]
19.

Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.

Kuo TC, Chang PY, Huang SF, Chou CK, Chao CC.

Biochem Pharmacol. 2012 Mar 15;83(6):758-68. doi: 10.1016/j.bcp.2011.12.034. Epub 2011 Dec 31.

PMID:
22230478
[PubMed - indexed for MEDLINE]
20.

HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.

Xiao Q, Qu K, Wang C, Kong Y, Liu C, Jiang D, Saiyin H, Jia F, Ni C, Chen T, Zhang Y, Zhang P, Qin W, Sun Q, Wang H, Yi Q, Liu J, Huang H, Yu L.

Gut. 2013 Mar;62(3):440-51. doi: 10.1136/gutjnl-2011-300781. Epub 2012 Apr 5.

PMID:
22490522
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk